CPIX Stock Analysis: Buy, Sell, or Hold?
CPIX - Cumberland Pharmaceuticals Inc
$6.37
-0.76 (-10.66%)
▼
5d:
+6.88%
30d:
+10.4%
90d:
+105.48%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When CPIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CPIX shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: CPIX shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CPIX is currently trading at $6.37, which is considered extended relative to its 30-day fair value range of $5.53 to $6.35.
Technical Outlook: Technically, CPIX is in a strong uptrend. The price is approaching resistance at $6.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 10.7% recently.
Market Sentiment: CPIX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+33.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CPIX is in a strong uptrend. The price is approaching resistance at $6.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 10.7% recently.
Market Sentiment: CPIX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+33.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.53 -
$6.35
Company Quality Score
60/100
(BUY)
Options IV Signal
35th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 35th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.7%)
- BULLISH: Trading 33.4% below Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$5.53 -
$6.35
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.47
(23.0%)
Support & Resistance Levels
Support Level
$5.44
Resistance Level
$6.10
Current Trend
Strong Uptrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.00
Wall Street Target
$8.50
(+33.4%)
Revenue Growth (YoY)
-22.0%
Profit Margin
-17.6%
Share & Embed Analysis
Last updated: July 02, 2026 11:40 PM ET
Data refreshes hourly during market hours. Next update: 12:40 AM
Data refreshes hourly during market hours. Next update: 12:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
